Claudio Viscoli
Impact in
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance
Papers in
-
- Antifungal resistance and susceptibility 83
- HIV/AIDS drug development and treatment 21
- HIV/AIDS Research and Interventions 20
- Epidemiology 115
- Fungal Infections and Studies 55
- Co-authors
- Matteo Bassetti (50 shared papers)Małgorzata Mikulska (56 shared papers)Elio Castagnola (44 shared papers)Valerio Del Bono (56 shared papers)Thierry Calandra (13 shared papers)Daniele Roberto Giacobbe (37 shared papers)M. P. Glauser (16 shared papers)Mario Tumbarello (15 shared papers)
- Journals
- Clinical Infectious Diseases (18 papers)Clinical Microbiology and Infection (14 papers)Journal of Chemotherapy (12 papers)Journal of Antimicrobial Chemotherapy (11 papers)BMC Infectious Diseases (9 papers)
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Claudio Viscoli
299 papers receiving 14.5k citations
Claudio Viscoli's Hit Papers
Peers
Comparison fields: 5 of 143
- Molecular Medicine 3.1k
- Applied Microbiology and Biotechnology 1.0k
- Infectious Diseases 5.7k
- Clinical Biochemistry 1.8k
- Epidemiology 5.3k
Countries citing papers authored by Claudio Viscoli
This map shows the geographic impact of Claudio Viscoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Viscoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Viscoli more than expected).
Fields of papers citing papers by Claudio Viscoli
This network shows the impact of papers produced by Claudio Viscoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Viscoli. The network helps show where Claudio Viscoli may publish in the future.
Co-authors
The 25 scholars most cited alongside Claudio Viscoli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 302 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy Hit paper breakdown → | 2012 | 755 |
| 2 | International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) Hit paper breakdown → | 2019 | 676 |
| 3 | 1999 | 484 | |
| 4 | ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients Hit paper breakdown → | 2016 | 439 |
| 5 | European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia Hit paper breakdown → | 2013 | 431 |
| 6 | 2015 | 400 | |
| 7 | 2005 | 390 | |
| 8 | 2013 | 315 | |
| 9 | 2006 | 274 | |
| 10 | 1999 | 256 | |
| 11 | 2010 | 224 | |
| 12 | 1997 | 220 | |
| 13 | 2011 | 204 | |
| 14 | 1996 | 202 | |
| 15 | 2013 | 197 | |
| 16 | 2014 | 196 | |
| 17 | 2007 | 195 | |
| 18 | 2004 | 192 | |
| 19 | 1995 | 192 | |
| 20 | 2011 | 178 |
About Claudio Viscoli
Claudio Viscoli is a scholar working on Infectious Diseases, Epidemiology, Oncology, Molecular Medicine and Emergency Medicine, having authored 302 papers that have together received 14.8k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (83 papers), Neutropenia and Cancer Infections (73 papers), Fungal Infections and Studies (55 papers), Antibiotic Resistance in Bacteria (33 papers), Bacterial Identification and Susceptibility Testing (31 papers), Antibiotics Pharmacokinetics and Efficacy (28 papers), HIV/AIDS drug development and treatment (21 papers) and HIV/AIDS Research and Interventions (20 papers). The work is most often cited by research in Molecular Medicine (3.1k citations), Applied Microbiology and Biotechnology (1.0k citations), Infectious Diseases (5.7k citations), Clinical Biochemistry (1.8k citations) and Epidemiology (5.3k citations). Claudio Viscoli has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Matteo Bassetti, Małgorzata Mikulska, Elio Castagnola, Valerio Del Bono, Thierry Calandra, Daniele Roberto Giacobbe, M. P. Glauser, Mario Tumbarello, Andrea Bacigalupo and Elda Righi. Their work appears in journals such as Clinical Infectious Diseases, Clinical Microbiology and Infection, Journal of Chemotherapy, Journal of Antimicrobial Chemotherapy and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.